What a great end to the week looks like we are on the uptrend again, personally expecting TGA to change their stance on RATS over next few weeks as the state governments and federal gov move to reopening phase. They will need to implement procedures early to establish what is working and what is not before letting us all out of our cages and back to the new normal. Very much looking forward to Thursday update webinar will be great to hear from the company directly and hoping some battery updates are forthcoming they must be getting close to reaching goals with current projects. COVID ain’t going anywhere and US and UK are a good litmus test for us here and RATS are certainly beginning to get recognition as a viable ongoing proposition to dampen spread. Expect TGA approval to be lodged prior to webinar and also Indian trial if not complete should have plenty of data sets that have been scrutinised by the company by now so a few questions should be put forward into saliva use case vs nasal vs shallow nasal vs throat swab and how results differ in accuracy. Next week looking like it will be a good one. Stay well all we are on a winner here.
ADO Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
